BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16205246)

  • 1. Documenting an adverse drug reaction.
    Smith LS
    Nursing; 2005 Oct; 35(10):22. PubMed ID: 16205246
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA's sentinel network: a monumental task.
    Young D
    Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
    [No Abstract]   [Full Text] [Related]  

  • 3. Human factors and medical IT systems: complex incident reporting systems and multiple IV infusions.
    Colvin C; Baird P; Easty T; Trbovich P
    Biomed Instrum Technol; 2013; Suppl():59-63. PubMed ID: 24111773
    [No Abstract]   [Full Text] [Related]  

  • 4. Incident reports are a must.
    Sullivan GH
    RN; 2003 Nov; 66(11):71-4. PubMed ID: 14685999
    [No Abstract]   [Full Text] [Related]  

  • 5. Documenting known or suspected medical device failure.
    Smith LS
    Nursing; 2004 Jul; 34(7):28. PubMed ID: 15241274
    [No Abstract]   [Full Text] [Related]  

  • 6. With REMS, what goes up can come down.
    Thompson CA
    Am J Health Syst Pharm; 2011 May; 68(9):783-4. PubMed ID: 21515857
    [No Abstract]   [Full Text] [Related]  

  • 7. Shared REMS programs expanded in 2012.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(4):298, 303. PubMed ID: 23370134
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancing the reporting of "near miss" events in a children's emergency department.
    Aston E; Young T
    J Emerg Nurs; 2009 Sep; 35(5):451-2. PubMed ID: 19748029
    [No Abstract]   [Full Text] [Related]  

  • 9. Keeping it straight: the importance of keeping records.
    Qld Nurse; 2005; 24(5):18. PubMed ID: 16255412
    [No Abstract]   [Full Text] [Related]  

  • 10. IOM panel mulls over adverse-event reporting.
    Young D
    Am J Health Syst Pharm; 2005 Dec; 62(24):2590-1. PubMed ID: 16333055
    [No Abstract]   [Full Text] [Related]  

  • 11. Where are risk evaluation and mitigation strategies headed?
    Johnson PE
    Am J Health Syst Pharm; 2010 Sep; 67(18):1511. PubMed ID: 20811027
    [No Abstract]   [Full Text] [Related]  

  • 12. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
    Kessler DA
    Gen Hosp Psychiatry; 1994 Mar; 16(2):96-101; discussion 102. PubMed ID: 8039699
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug reactions.
    Roswell R; Van Diepen LR; Jones JK; Hicks WE
    Lancet; 2001 Feb; 357(9255):561-2. PubMed ID: 11229704
    [No Abstract]   [Full Text] [Related]  

  • 14. Data incompatibility of adverse event reports electronically submitted to the AERS database.
    Glass LM
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):212-3. PubMed ID: 18236510
    [No Abstract]   [Full Text] [Related]  

  • 15. Documenting adverse incidents.
    Stewart KB
    Nursing; 2001 Mar; 31(3):84. PubMed ID: 11288565
    [No Abstract]   [Full Text] [Related]  

  • 16. Reporting Adverse Drug Events.
    Feagins LA; Abdelsayed GG; Schairer J;
    Am J Gastroenterol; 2019 Sep; 114(9):1411-1413. PubMed ID: 31464745
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA Encourages Reporting of Tobacco Product Adverse Experiences.
    Retzky SS
    Chest; 2016 Dec; 150(6):1169-1170. PubMed ID: 27938736
    [No Abstract]   [Full Text] [Related]  

  • 18. Issues related to risk evaluation and mitigation strategies in health-system pharmacy.
    Coffey J
    Am J Health Syst Pharm; 2010 Sep; 67(18):1512. PubMed ID: 20811028
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists.
    Stubbings J; Joshi RA; Hoffman JM
    Am J Health Syst Pharm; 2010 Sep; 67(18):1547-54. PubMed ID: 20811034
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring and managing adverse drug reactions.
    Fincham JE
    Am Pharm; 1992 Feb; NS32(2):74-81. PubMed ID: 1546634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.